Related Experiment Videos
Anaphylaxis to rocuronium
C Baillard1, A M Korinek, V Galanton
1Département d'anesthésie, Hôpital Avicenne, Bobigny, France.
British Journal of Anaesthesia
|June 18, 2002
Summary
Rocuronium can cause severe anaphylaxis, a serious allergic reaction, with recent reports highlighting its potential for fatal outcomes. Vigilance and prompt management are crucial for patients experiencing these adverse events.
Area of Science:
- Anesthesiology
- Pharmacology
- Immunology
Background:
- Anaphylactic and anaphylactoid reactions to rocuronium, a neuromuscular blocking agent, have been increasingly reported.
- These reactions can be severe, necessitating a thorough understanding of their clinical presentation and management.
Observation:
- Two cases of documented grade III anaphylaxis following rocuronium administration are presented.
- The first case involved an 81-year-old woman experiencing severe hypotension and tachycardia, who recovered after resuscitation.
- The second case involved a 64-year-old man with severe hemodynamic instability and bronchospasm, complicated by multiple organ failure and death.
Findings:
- Rocuronium-induced anaphylaxis can manifest with varying severity, from transient hypotension to life-threatening multi-organ failure.
- Prompt recognition and management, including hemodynamic support and bronchodilator therapy, are critical.
Implications:
- These cases underscore the importance of heightened awareness and preparedness for severe anaphylactic reactions to rocuronium in surgical settings.
- Further research into the mechanisms and prevention of rocuronium-induced anaphylaxis is warranted.